564 related articles for article (PubMed ID: 32210127)
1. Nanostructured Lipid Carriers for Delivery of Chemotherapeutics: A Review.
Haider M; Abdin SM; Kamal L; Orive G
Pharmaceutics; 2020 Mar; 12(3):. PubMed ID: 32210127
[TBL] [Abstract][Full Text] [Related]
2. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers: Structure, Preparation and Application.
Naseri N; Valizadeh H; Zakeri-Milani P
Adv Pharm Bull; 2015 Sep; 5(3):305-13. PubMed ID: 26504751
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured lipid carriers, solid lipid nanoparticles, and polymeric nanoparticles: which kind of drug delivery system is better for glioblastoma chemotherapy?
Qu J; Zhang L; Chen Z; Mao G; Gao Z; Lai X; Zhu X; Zhu J
Drug Deliv; 2016 Nov; 23(9):3408-3416. PubMed ID: 27181462
[TBL] [Abstract][Full Text] [Related]
4. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery.
Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X
Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691
[TBL] [Abstract][Full Text] [Related]
5. Methods for preparation of nanostructured lipid carriers.
Gomaa E; Fathi HA; Eissa NG; Elsabahy M
Methods; 2022 Mar; 199():3-8. PubMed ID: 33992771
[TBL] [Abstract][Full Text] [Related]
6. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
Fang CL; Al-Suwayeh SA; Fang JY
Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
[TBL] [Abstract][Full Text] [Related]
7. Recent Advances in Lipid-based Nanodrug Delivery Systems in Cancer Therapy.
Layek B; Gidwani B; Tiwari S; Joshi V; Jain V; Vyas A
Curr Pharm Des; 2020; 26(27):3218-3233. PubMed ID: 32568015
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages.
Ghasemiyeh P; Mohammadi-Samani S
Res Pharm Sci; 2018 Aug; 13(4):288-303. PubMed ID: 30065762
[TBL] [Abstract][Full Text] [Related]
9. Effective Delivery Routes And Strategies For Solid Lipid Nanoparticles (Sln) And Nanostructured Lipid Carriers (Nlc).
Shastri DH
Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29173154
[TBL] [Abstract][Full Text] [Related]
10. Solid lipid matrix mediated nanoarchitectonics for improved oral bioavailability of drugs.
Banerjee S; Pillai J
Expert Opin Drug Metab Toxicol; 2019 Jun; 15(6):499-515. PubMed ID: 31104522
[No Abstract] [Full Text] [Related]
11. Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors.
Mehrdadi S
Adv Pharm Bull; 2023 Jul; 13(3):512-520. PubMed ID: 37646057
[TBL] [Abstract][Full Text] [Related]
12. Development of solid lipid nanoparticles and nanostructured lipid carriers for improving ocular delivery of acyclovir.
Seyfoddin A; Al-Kassas R
Drug Dev Ind Pharm; 2013 Apr; 39(4):508-19. PubMed ID: 22424312
[TBL] [Abstract][Full Text] [Related]
13. Lipid-core nanoparticles: Classification, preparation methods, routes of administration and recent advances in cancer treatment.
Graván P; Aguilera-Garrido A; Marchal JA; Navarro-Marchal SA; Galisteo-González F
Adv Colloid Interface Sci; 2023 Apr; 314():102871. PubMed ID: 36958181
[TBL] [Abstract][Full Text] [Related]
14. Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs?
Das S; Ng WK; Tan RB
Eur J Pharm Sci; 2012 Aug; 47(1):139-51. PubMed ID: 22664358
[TBL] [Abstract][Full Text] [Related]
15. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
Wang W; Chen L; Huang X; Shao A
AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
[TBL] [Abstract][Full Text] [Related]
16. Recent advances and patents on solid lipid nanoparticles.
Sawant KK; Dodiya SS
Recent Pat Drug Deliv Formul; 2008; 2(2):120-35. PubMed ID: 19075903
[TBL] [Abstract][Full Text] [Related]
17. [Effect of nanostructured lipid carriers (NLCs) in improving stability of essential oils and its application].
Li Y; Wu ZF; Kuang WW; Li YH; Chen BY; Yang M
Zhongguo Zhong Yao Za Zhi; 2020 Feb; 45(3):523-530. PubMed ID: 32237509
[TBL] [Abstract][Full Text] [Related]
18. Applications of Lipid-based Nanocarriers for Parenteral Drug Delivery.
Santonocito D; Puglia C
Curr Med Chem; 2022; 29(24):4152-4169. PubMed ID: 34983336
[TBL] [Abstract][Full Text] [Related]
19. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting.
Rajoriya V; Gupta R; Vengurlekar S; Surendra Singh U
Int J Pharm; 2024 Apr; 655():123986. PubMed ID: 38493842
[TBL] [Abstract][Full Text] [Related]
20. A Review of the Structure, Preparation, and Application of NLCs, PNPs, and PLNs.
Li Q; Cai T; Huang Y; Xia X; Cole SPC; Cai Y
Nanomaterials (Basel); 2017 May; 7(6):. PubMed ID: 28554993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
